tiprankstipranks
Trending News
More News >
Integrum AB Class B (DE:6Y1)
:6Y1

Integrum AB Class B (6Y1) Price & Analysis

Compare
0 Followers

6Y1 Stock Chart & Stats


---

Financials

Quarterly

6Y1 FAQ

What was Integrum AB Class B’s price range in the past 12 months?
Integrum AB Class B lowest stock price was €1.30 and its highest was €5.30 in the past 12 months.
    What is Integrum AB Class B’s market cap?
    Integrum AB Class B’s market cap is €30.07M.
      When is Integrum AB Class B’s upcoming earnings report date?
      Integrum AB Class B’s upcoming earnings report date is Jun 03, 2025 which is in 56 days.
        How were Integrum AB Class B’s earnings last quarter?
        Integrum AB Class B released its earnings results on Mar 03, 2025. The company reported -€0.016 earnings per share for the quarter, beating the consensus estimate of -€0.035 by €0.019.
          Is Integrum AB Class B overvalued?
          According to Wall Street analysts Integrum AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Integrum AB Class B pay dividends?
            Integrum AB Class B does not currently pay dividends.
            What is Integrum AB Class B’s EPS estimate?
            Integrum AB Class B’s EPS estimate is -0.02.
              How many shares outstanding does Integrum AB Class B have?
              Integrum AB Class B has 20,694,328 shares outstanding.
                What happened to Integrum AB Class B’s price movement after its last earnings report?
                Integrum AB Class B reported an EPS of -€0.016 in its last earnings report, beating expectations of -€0.035. Following the earnings report the stock price went down -0.694%.
                  Which hedge fund is a major shareholder of Integrum AB Class B?
                  Currently, no hedge funds are holding shares in DE:6Y1
                  ---

                  Company Description

                  Integrum AB Class B

                  Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Q-linea AB
                  Acarix AB
                  BrainCool AB
                  Doxa AB
                  Mentice AB
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis